经尿道同期处理膀胱肿瘤合并前列腺增生的临床观察  

作　　者：刘磊[1] 于鹏[1] 刘雍[1] 解放[1] 王军[1] 

机构地区：[1]威海市立医院泌尿外科,山东省264200

出　　处：《中华临床医师杂志（电子版）》2016年第4期43-43,共1页Chinese Journal of Clinicians(Electronic Edition)

摘　　要：目的 探讨经尿道等离子电切术同期治疗膀胱肿瘤合并前列腺增生症的疗效和安全性.方法 回顾性分析我院2012年10月至2015年1月16例同期行经尿道等离子电切术治疗膀胱肿瘤合并前列腺增生16例患者的临床资料.结果 所有患者均顺利完成手术,随访12-36个月,1例发生膀胱腔内肿瘤复发,所有病例均未发生前列腺窝、后尿道肿瘤种植.结论 前列腺增生合并膀胱肿瘤患者同期行经尿道等离子电切术是安全可行的,疗效满意,并不增加膀胱肿瘤后尿道及前列腺窝种植的风险.Objective To evaluate the efficacy and safety of simultaneous transurethral resection of benign prostatic hyperplasia（BPH）and bladdertransitional cell carcinoma（BTCC）with plasmakinetic technique.Methods 16 patients with BTCC and BPH had undergone plasmakinetic resection of thebladder tumor（PKRBT）and plasmakinetic resection of the prostate（PKRP）at the same time,and had been followed up postoperatively to view theresult.Results No transurethral resection syndrome occurred in those patients.The following up period ranged from 12-36 months.The recurrence occurredto 1 cases without implaneation at the bladder neck and prostatic urethra metastase.Conclusions PKRBT and PKRP at the same time is a safe,effective,reliable method for patients with BTCC and BPH.Do not increase the recurrence risk of implaneation at the bladder neck and prostatic urethra metastase.

关 键 词：膀胱肿瘤 前列腺增生 等离子电切 

分 类 号：R697.32[医药卫生—泌尿科学]